Search for: "Merck & Co., Inc. "
Results 461 - 480
of 664
Sort by Relevance
|
Sort by Date
11 Sep 2009, 10:33 am
Merck & Co., Inc. [read post]
4 Sep 2009, 12:11 pm
(quoting Merck & Co. v. [read post]
2 Sep 2009, 11:22 pm
Merck & Co., 949 A.2d 223, 271-76 (N.J. [read post]
1 Sep 2009, 8:12 am
Merck & Co. [read post]
23 Aug 2009, 7:18 pm
Building Trades Plan on behalf of itself and all others similarly situated • Defendants: Merck & Co., Inc.; Merck Sharp & Dohme Pharmaceuticals SRL Antitrust action for monopolization of the market for montelukast sodium products (Merck's... [read post]
11 Aug 2009, 8:34 pm
Co. v. [read post]
11 Aug 2009, 2:02 pm
Am Law Daily's Priti Patnaik writes about the Boles case: Starting Tuesday, pharma giant Merck & Co., Inc. faces the first trial over its osteoporosis drug Fosamax. [read post]
30 Jul 2009, 7:02 am
"Statement by Merck & Co., Inc. [read post]
14 Jul 2009, 5:07 am
Merck & Co., Inc., 192 N.J. 372 (2007), referred to as Vioxx by the district court, the federal court refused to grant class action treatment to the litigation because “Vioxx precludes NJCFA plaintiffs from establishing causation through a report from a single expert, and the instant plaintiffs seek to do exactly that,” id., at 25. [read post]
2 Jul 2009, 5:18 am
Philip Morris, Inc., ___ P.3d ___, 2009 WL 1563373 (Nev. [read post]
1 Jul 2009, 7:14 am
OHIM decision in Laboratorios Andrómaco, S.A. v OTC Pharma International B V (Class 46) India: Valgancyclovir hearings and the need for more transparency: Roche v Cipla (Spicy IP) Japan approves first follow-on biologic (Patent Docs) UK: Journal of Intellectual Property Law & Practice note on ‘Paediatric extensions: the requirement of a compliance statement’ on UK IPO decision in Merck and Co, Inc (The SPC Blog) US: Sen Nelson… [read post]
23 Jun 2009, 2:44 pm
Merck Statement in Response to the FDA's June 12, 2009 Communication with Updated Information on Leukotriene Inhibitors, Including SINGULAIR ® (montelukast sodium) -- June 12, 2009 press release from Merck & Co., Inc. [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever changing landscape Pirate Party,… [read post]
22 Jun 2009, 5:00 am
We are discussing Merck v. [read post]
10 Jun 2009, 10:00 pm
Upjohn Co., 950 F. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent… [read post]
31 May 2009, 2:37 am
Young is the first named inventor of US 5,104,882, which ALSO arose out of Merck Frosst Canada, Inc. [read post]
27 May 2009, 4:09 am
Merck & Co. [read post]
26 May 2009, 7:07 am
Docket: 08-905 Title: Merck & Co., Inc., et al., Petitioners v. [read post]
